Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network.

Saved in:
Bibliographic Details
Title: Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network.
Authors: Avutu V; Department of Medicine, Memorial Sloan Kettering Cancer Center; New York, NY., Monga V; Division of Medical Oncology, Department of Internal Medicine, University of Iowa, Iowa City, IA., Mittal N; Division of Pediatric Hematology Oncology, Department of Pediatrics, Rush University Medical Center, Chicago, IL., Saha A; Division of Pediatric Hematology-Oncology, University of South Carolina School of Medicine, Greenville, SC., Andolina JR; Department of Pediatrics, Golisano Children's Hospital, University of Rochester Medical Center, Rochester, NY., Bell DE; Department of Pediatrics, Ascension St John Hospital, Detroit, MI., Fair DB; Division of Hematology/Oncology, Department of Pediatrics, University of Utah, Primary Children's Hospital, Huntsman Cancer Institute, Salt Lake City, UT., Flerlage JE; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN., Frediani JN; Department of Pediatrics, University of California, Irvine, CA., Heath JL; Departments of Pediatrics and Biochemistry, University of Vermont, Burlington, VT., Kahn JM; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, NY., Reichek JL; Division of Hematology/Oncology/Stem Cell Transplantation, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL., Super L; Department of Paediatrics, School of Medicine, Monash University, Melbourne, Australia., Terao MA; Division of Pediatric Adolescent and Young Adult Hematology and Oncology, Department of Pediatrics, Medstar Georgetown University Hospital, Washington, DC., Freyer DR; Departments of Pediatrics, Medicine, and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA., Roth ME; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX.
Source: JCO oncology practice [JCO Oncol Pract] 2022 Mar; Vol. 18 (3), pp. 224-231. Date of Electronic Publication: 2021 Dec 14.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Consensus Statement
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2688-1535
DOI:10.1200/OP.21.00554